4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0000899243-17-013254
President and CEO acquired 93,211 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hughes Thomas E. President and CEO | 2017-05-11 | Option exercise | +18,928 | $0.75 | $14,196 | 83,088 | D: show line 1 in the form |
| Hughes Thomas E. President and CEO | 2017-05-11 | Option exercise | +6,210 | $0.75 | $4,658 | 89,298 | D: show line 2 in the form |
| Hughes Thomas E. President and CEO | 2017-05-11 | Option exercise | +68,073 | $0.82 | $55,820 | 157,371 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hughes Thomas E. President and CEO | 2017-05-11 | Option exercise · Stock Option (Right to Buy | −18,928 | 0 | D: show line 4 in the form | ||
| Hughes Thomas E. President and CEO | 2017-05-11 | Option exercise · Stock Option (Right to Buy) | −6,210 | 0 | D: show line 5 in the form | ||
| Hughes Thomas E. President and CEO | 2017-05-11 | Option exercise · Stock Option (Right to Buy) | −68,073 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…